ライフサイエンスコーパス: fever

1 or arboviruses (e.g. dengue, zika and yellow fever).

2 in individuals with recent suspected enteric fever.

3 redictive of blood culture-confirmed enteric fever.

4 tic of clinical manifestation of a prolonged fever.

5 n in platelet counts, and dengue hemorrhagic fever.

6 microbiota with adult asthma, atopy, and hay fever.

7 for the management of pain, inflammation and fever.

8 Seven patients presented with a fever.

9 (26.7%) had blood culture-confirmed enteric fever.

10 novel therapeutic strategies against typhoid fever.

11 covery rate, <0.05) by asthma, atopy, or hay fever.

12 lular bacterium and the causative agent of Q fever.

13 rm public health policies to prevent enteric fever.

14 e licensed or in development against typhoid fever.

15 d less relapses in culture-confirmed enteric fever.

16 te between malaria and alternative causes of fever.

17 ained blood cultures to evaluate for enteric fever.

18 lis, leptospirosis, and tick-borne relapsing fever.

19 ere more abundant with asthma, atopy, or hay fever.

20 an inform public health responses to enteric fever.

21 us but was lower (P < .05) with atopy or hay fever.

22 these, 39.8% (n = 175) had neither cough nor fever.

23 we meet with the adult patient of recurrent fever.

24 eases like cancer, ulcers, tumor, asthma and fever.

25 alongside other measures to prevent enteric fever.

26 he DMH that is required for cold defense and fever.

27 % (31.9 to 97.1) against dengue haemorrhagic fever.

28 ccine candidates for other viral hemorrhagic fevers.

29 h (2 points), headache (1 point), subjective fever (1 point), and triage temperature >100.4 degrees C

30 SARS-CoV-2) that uses live-attenuated yellow fever 17D (YF17D) vaccine as a vector to express a noncl

31 ymptoms included cough (66%), dyspnea (50%), fever (47%), and gastrointestinal upset (44%).

32 The most common presenting symptoms were fever (49%) and cough (39%); initial radiographs most co

33 ease, 133 (94%) children had rash, 104 (74%) fever, 67 (48%) arthralgia, and 51 (36%) conjunctivitis.

34 Patients presented most often with a fever (87%) and/or cough (67%).

35 re therapeutic strategy against severe Lassa fever, a hypothesis that could be tested in relevant ani

36 behavioural symptoms during the course of a fever, a sign of systemic inflammation(1,2).

37 We therefore estimate that typhoid fever accounts for 43% of all bowel perforation during t

38 Orientia tsutsugamushi, is a major cause of fever across the Asia Pacific region with more than a bi

39 show that fever acts through a T cell-intrinsic SMAD4-dependent me

40 d the number of annual Argentine hemorrhagic fever (AHF) cases.

41 ysiological processes, such as inflammation, fever, allergy, and pain, their roles in COVID-19 are po

42 igh burden of hospitalization due to enteric fever among children aged <5 years in Bangladesh.

43 rted symptoms and clinical signs, of enteric fever among patients participating in the Surveillance f

44 ted at mid-gestation and monitored daily for fever and abortions.

45 rapid, as judged by significant decrease of fever and C-reactive protein at day 3.

46 r their impact in the clinical management of fever and common infectious syndromes in nonneutropenic

47 Fever and cough are the dominant symptoms with 15% of pa

48 nce mild clinical symptoms, including a high fever and dry cough.

49 ions, but 1 of 4 RFA animals (25%) developed fever and dyspnea.

50 shock and alleviates familial Mediterranean fever and experimental autoimmune encephalitis by target

51 er, eliciting symptoms that range from acute fever and fatigue to chronic fatal endocarditis.

52 n-typhoidal Salmonelleae (NTS) cause typhoid fever and gastroenteritis, respectively, in humans.

53 Persistent fever and gastrointestinal symptoms are the most common

54 rged of children with an unusual syndrome of fever and inflammation.

55 enting with >=3 consecutive days of reported fever and inpatients with clinically suspected enteric f

56 n March 23 and May 16, 2020, with persistent fever and laboratory evidence of inflammation meeting pu

57 nsistent with the development of hemorrhagic fever and lymphopenia.

58 the ferret respiratory tract, causing slight fever and moderate weight loss.

59 ly to have obesity, more frequently reported fever and myalgia, and had lower D-dimer levels compared

60 All children presented with fever and nonspecific symptoms, including vomiting (26/5

61 we investigated if clinical features such as fever and parasite density could act as predictors of pa

62 Vaccination with both vaccines prevented fever and protected against abortion.

63 tion of age >5 years (AUC = 0.77), prodromal fever and respiratory symptoms >6 days (AUC = 0.79), and

64 x cases from Nigeria, the majority developed fever and self-limiting vesiculopustular skin eruptions.

65 ienced a 9-week course of COVID-19 with high fever and severe viral pneumonia.

66 has the potential to cause fatal hemorrhagic fever and shock.

67 of 10 583 staff were placed on hospitalwide fever and sickness surveillance, with 1524 frontline sta

68 Children less than five years with fever and/or ARI symptoms were recruited from the emerge

69 ty patients had diarrhea, 8 bloody stools, 4 fever, and 1 hypothermia.

70 prolonged prodromal respiratory symptoms and fever, and extrapulmonary (skin) manifestations.

71 erovar Typhi, the causative agent of typhoid fever, and is thought to be responsible for the symptoms

72 e greater in adults with current asthma, hay fever, and pollen sensitization.

73 resources used to diagnose and treat enteric fever, and procedure frequencies received at these facil

74 nia characterized by a dry cough, persistent fever, and progressive dyspnea and hypoxia, sometimes ac

75 ur study further demonstrated that asplenia, fever, and reduced O(2) saturation, along with low Hb an

76 We report an adult case of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (P

77 Periodic fever, aphthous stomatitis, pharyngitis, and cervical ad

78 COVID-19 and dengue fever are difficult to distinguish given shared clinical

79 at the neurons that express EP3R and mediate fever are glutamatergic, not GABAergic.

80 Malarial rhythmic fevers are the consequence of the synchronous bursting o

81 oses (SFR), including Rocky Mountain spotted fever, are tick-borne infections with frequent neurologi

82 African swine fever (ASF) is a severe viral disease that is currently

83 nce of any available vaccines, African swine fever (ASF) outbreak containment relies on the control a

84 its own replication.IMPORTANCE African swine fever (ASF) poses a major threat to pig populations and

85 Rheumatic fever-associated emm types were disseminated throughout

86 o analyze the protein diversity of rheumatic fever-associated strains in a phylogenetic tree and to i

87 roject (SEAP) to assess incidence of enteric fever at 6 study hospitals in 3 countries.

88 We report the burden of enteric fever at selected sites of Karachi, Pakistan.

89 ar-old man had been suffering from recurrent fever attack once in 1-2 months during childhood.

90 the causative agent of Bolivian hemorrhagic fever (BHF), is a New World arenavirus that was first is

91 Enteric fever can impose a considerable economic burden in Pakis

92 Enteric fever can impose a considerable economic burden on patie

93 idea that fasting when feverish ("starving a fever") can increase the pace of recovery, or that showe

94 s of 0.046 perforations per clinical typhoid fever case (95% CI, .03-.06).

95 Of the 8705 blood culture-confirmed enteric fever cases enrolled, we identified 6 deaths (case-fatal

96 Enteric fever cases have increased during the last 3 years with

97 al diagnoses, but 31% (1147/3754) of enteric fever cases were not covered by initial therapy; this wa

98 rolled 8,705 blood culture confirmed enteric fever cases: 4,873 (56%) from Bangladesh, 1,602 (18%) fr

99 a fever (LF) is a zoonotic viral hemorrhagic fever caused by Lassa virus (LASV), which is endemic to

100 vaccines are available to combat hemorrhagic fever caused by mammarenavirus infections in humans.

101 Enteric fever causes substantial morbidity and mortality in low-

102 fer insight into the pathogenesis of scarlet fever-causing GAS mediated by prophage PhiHKU.vir exotox

103 Crimean-Congo hemorrhagic fever (CCHF) is the most widely distributed tick-borne v

104 ere and fatal SFTS presents as a hemorrhagic fever characterized by high viral load, uncontrolled inf

105 n; and current runny nose, nasal congestion, fever, chest indrawing, or cyanosis.

106 tamivir; however, she had continued fatigue, fever, chills, abdominal bloating, and loss of appetite.

107 er, she had continued to experience fatigue, fever, chills, abdominal bloating, and loss of appetite.

108 d a 1-month history of abdominal distention, fevers, chills, and flu-like symptoms.

109 The combination of cough and fever/chills has 4.2-fold amplification in COVID(pos) pa

110 The primary endpoint was fever clearance time (FCT); secondary endpoints were tre

111 Using a mouse model of chronic typhoid fever combined with major histocompatibility complex (MH

112 These new estimates of enteric fever cost of illness can improve evaluation and modelin

113 A definition based on these four (measured fever, cough, chills or myalgia), was 95% sensitive and

114 Reporting fever, cough, or shortness of breath in the last week du

115 orized as symptomatic with typical symptoms (fever, cough, or shortness of breath), symptomatic with

116 The presenting features were fever, cough, rhinorrhea, and hypoxemia.

117 eview the history of the medical approach to fever, current diagnostic paradigms, and controversies i

118 from red blood cells, which triggers 48-hour fever cycles in the host.

119 the causative agent of Argentine hemorrhagic fever, demonstrating the feasibility of using TCRV as a

120 o explore the effects of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine (CYD-TDV, Dengv

121 Fever developed between day 14 to 18 postinoculation, an

122 mained unchanged in those with DHF or dengue fever (DF) during febrile and critical phases.

123 function in COVID-19 and dengue haemorrhagic fever (DHF) are two diseases that can associate with an

124 ver to severe disease, or dengue hemorrhagic fever (DHF).

125 lored with the aim of creating a new enteric fever diagnostic to work in conjunction with TCV.

126 s reported with the aid of the patient's hay-fever diary (PHD).

127 pectrum of disorders referred to a recurrent fever disorders clinic established in an Allergy/Immunol

128 virus infects airway and lung cells causing fever, dry cough, and shortness of breath.

129 The most common symptoms are fever, dry cough, and shortness of breath.

130 uded information on treatment delay, such as fever duration (inception to 22nd September 2017).

131 Median fever duration was 4 weeks (range, 2-9).

132 otyped lentiviral assay, and the presence of fever during illness.

133 The mechanisms involved in hypothermia and fever during systemic inflammation (SI) remain largely u

134 a burnetii is the causative agent of human Q fever, eliciting symptoms that range from acute fever an

135 hypotonia, feeding abnormalities, recurrent fever episodes, and infantile spasms .

136 e need a sustained effort within the enteric fever field to accelerate, validate, and ultimately intr

137 oinflammatory disease Familial Mediterranean Fever (FMF) map to exon 10 encoding the B30.2 domain.

138 plant recipients with familial Mediterranean fever (FMF)-associated AA amyloidosis.

139 displayed classical symptoms commencing with fever, followed by peripheral desquamation, strawberry t

140 inpatients with clinically suspected enteric fever from all 6 SEAP study hospitals were eligible to p

141 t prognostic factors include age >=65 years, fever, GCS score <13, and seizures.

142 dently associated with an ACO were age >=65, fever, Glasgow Coma Scale (GCS) score <13, and seizures

143 tolerated, but a high percentage developed a fever >=37.5 degrees C, necessitating urgent screening f

144 Among the patients with ACS, fever (>38.5 degrees C), reduced oxygen saturation (<95)

145 determined in consecutive adults with acute fever (>=38 degrees C) at presentation to outpatient cli

146 group A Streptococcus, GAS) to cause scarlet fever has been linked epidemiologically to the presence

147 defined as return to usual activities, with fever, headache, and muscle ache minor or absent.

148 viruses, e.g., SARS-CoV-2, influenza, dengue fever, hepatitis C virus, HIV, rotavirus and Zika virus.

149 SEAP) data to estimate the burden of enteric fever hospitalization among children aged <15 years and

150 onella Typhi contributed most to the enteric fever hospitalization incidence (277/100 000 children/ye

151 in 2012 who presented on March 20, 2020 with fever, hypoxia, and ground-glass opacities on chest X-ra

152 in response to primary and secondary yellow fever immunization - the model for acute infection in hu

153 subsets of cCXCR5(+) T cell following yellow fever immunization.

154 ed population-based surveillance for enteric fever in 1 urban catchment (Kathmandu) and 1 periurban a

155 The first reported case of yellow fever in a kidney transplant recipient in Brazil and the

156 1 DENV) is considered a biomarker for dengue fever in an early stage.

157 e introduction, the Surveillance for Enteric Fever in Asia Project (SEAP) conducts prospective enteri

158 Here, we analyzed Surveillance for Enteric Fever in Asia Project (SEAP) data to estimate the burden

159 tals as part of the Surveillance for Enteric Fever in Asia Project (SEAP) II in Pakistan.

160 the population-based Surveillance of Enteric Fever in Asia Project (SEAP) in Bangladesh, Nepal and Pa

161 The Surveillance for Enteric Fever in Asia Project (SEAP) is a multicenter, multicoun

162 The Surveillance for Enteric Fever in Asia Project (SEAP) is a prospective study of e

163 hybrid model in the Surveillance for Enteric Fever in Asia Project (SEAP) to assess incidence of ente

164 articipating in the Surveillance for Enteric Fever in Asia Project (SEAP), a 3-year surveillance stud

165 The Surveillance for Enteric Fever in Asia Project (SEAP), a prospective surveillance

166 hok) as part of the Surveillance for Enteric Fever in Asia Project (SEAP).

167 survey used for the Surveillance for Enteric Fever in Asia Project in Nepal, we incorporated a geogra

168 show substantial economic burden of enteric fever in Bangladesh, with higher costs for patients rece

169 auses incurable and often lethal hemorrhagic fever in domestic pigs.

170 lth importance, the pathophysiology of Lassa fever in humans is poorly understood.

171 Dengue virus (DENV) infection causes dengue fever in humans, which can lead to thrombocytopenia show

172 five known NWAs that cause viral hemorrhagic fever in humans.

173 Only 39% had fever in the first 24 hours, whereas 41% had hypoxia at

174 of 37.5 degrees C or higher, or a history of fever in the past 24 h.

175 ek 12 and included a composite of absence of fever in the preceding week, C-reactive protein <20 mg/L

176 ect (SEAP) is a prospective study of enteric fever incidence in Nepal, Bangladesh, and Pakistan.

177 e study, characterized the burden of enteric fever, including illness severity, in selected settings

178 ical, and indirect costs per case of enteric fever incurred since illness onset by phone after enroll

179 Relapsing fever is a common clinical phenotype.

180 Q-fever is a flu-like illness caused by Coxiella burnetii

181 Mediterranean spotted fever is a reemerging acute tick-borne infection produce

182 Typhoid fever is caused by Salmonella enterica subspecies enteri

183 Enteric fever is endemic in Nepal and its economic burden is unk

184 Typhoid fever is endemic in the urban Kathmandu Valley of Nepal;

185 Crimean-Congo hemorrhagic fever is the most geographically widespread tick-borne v

186 The rise of the body temperature, or fever, is an important brain-orchestrated mechanism for

187 an man was admitted to our hospital for high fever, lack of appetite related to nausea and vomiting,

188 ates that culture-confirmed cases of typhoid fever lead to an excess of 0.046 perforations per clinic

189 ; tachycardia; thrombocytosis; leukocytosis; fever; leg edema; lower Barthel Index (BI) score; immobi

190 Lassa fever (LF) is a zoonotic viral hemorrhagic fever caused

191 ave been associated with survival from Lassa fever (LF), but the Lassa virus-specific memory response

192 ncluding Ebola virus disease (EVD) and Lassa fever (LF), highlight the urgent need for sensitive, dep

193 eported hallmarks of infection have included fever, malaise, anorexia, gastrointestinal complaints, t

194 e associated with severe LF.IMPORTANCE Lassa fever may cause severe disease in humans, in particular

195 at fever temperatures, and we report notable fever-mediated modulation of their cytokine commitment.

196 f responsible gene of familial Mediterranean fever, MEFV showed E148Q heterozygous mutation in exon 2

197 ect of geosmin on the behavior of the yellow fever mosquito Aedes aegypti.

198 establishes the male sex (M/m) in the yellow fever mosquito, Aedes aegypti Nix, a gene in the M-locus

199 he respiratory airways leading to dry cough, fever, myalgia, headache, fatigue, and diarrhea and can

200 h atopic symptoms (food allergy, n = 13; hay fever, n = 10; asthma, n = 7).

201 tive of unlikely bacterial pneumonia were no fever, no consolidation on chest radiograph, and absolut

202 SA criteria, baseline fulminant colitis, and fever of >38.5 degrees C.

203 Fever of unknown origin (FUO) is a rare manifestation of

204 acin, and doxycycline were administered upon fever onset for 10 days.

205 plague when administered within 2-6 hours of fever onset in African green monkeys (AGM).

206 of remdesivir starting 24 and 45 days after fever onset, pneumonia and spiking fevers remitted, but

207 antimicrobials would remain effective after fever onset.

208 was initiated from 0 to up to 30 hours after fever onset.

209 All presented with subjective fever or chills; 97% had tachycardia, 80% had gastrointe

210 al dengue fever to severe dengue hemorrhagic fever or dengue shock syndrome; however, the complexitie

211 ril 2014, we enrolled adult ED patients with fever or respiratory symptoms who met criteria for antiv

212 atients with blood culture-confirmed enteric fever or with a nontraumatic terminal ileal perforation,

213 here was no difference in rates of diarrhea, fever, or anemia by treatment arm at baseline and at all

214 s characterizing the transmission of enteric fever organisms through sewage and water, discuss recent

215 tal sampling for the surveillance of enteric fever organisms to provide data on community-level typho

216 Among 1992 pediatric typhoid fever patients, 1616 (81%) had traveled internationally

217 Relapsing fever pattern was reported in 52% of patients, weight lo

218 After ruling out Lassa fever, plasma samples from these epidemiologically-linke

219 were modified by current asthma, current hay fever, pollen sensitization, age, and other environmenta

220 The re-emergence of scarlet fever poses a new global public health threat.

221 odeling of the costs and benefits of enteric fever-prevention measures.

222 nd the lack of therapeutic agents for yellow fever put global health at risk, should this virus emerg

223 Given the presentation of fevers, rashes, and mucosal symptoms observed in many of

224 Adjustment for malaria and fever-recovery-related QT lengthening is necessary to av

225 Enteric fever remains a major cause of morbidity in developing c

226 Enteric fever remains a public health concern in communities lac

227 ays after fever onset, pneumonia and spiking fevers remitted, but relapsed after discontinuation.

228 tients not receiving chloroquine found minor fever resolution and virologic clearance benefits with c

229 Fever, respiratory symptoms, and dyspnea were the most f

230 VGluT2) but not MnPO(Vgat) neurons abolished fever responses but not changes in Tb induced by behavio

231 /signs including thrombocytopenia, anasarca, fever, reticulin fibrosis/renal dysfunction, and organom

232 n of evidence-based strategies for rheumatic fever/RHD prevention, (3) access to essential medication

233 The spotted fever rickettsioses (SFR), including Rocky Mountain spot

234 Rift Valley fever (RVF) is an emerging, zoonotic, arboviral hemorrha

235 Fever sensing by CD4 T cells involved transient receptor

236 Project (SEAP) conducts prospective enteric fever surveillance in Bangladesh, Nepal, and Pakistan.

237 ssa virus-specific T cell responses in Lassa fever survivors and vaccinated individuals as well as fo

238 dentify common T cell epitopes between Lassa fever survivors from Sierra Leone and Nigeria, where dis

239 Serum or plasma from Nigerian Lassa fever survivors neutralized LASV pseudoviruses expressin

240 humans and result in an early-onset periodic fever syndrome and severe intermittent lymphadenopathy-a

241 (PFAPA) syndrome is the most common periodic fever syndrome in children.

242 gan-specific inflammation, known as periodic fever syndromes.

243 Tick-borne relapsing fever (TBRF) is a neglected zoonotic bacterial disease k

244 the priming of naive CD4 T cells in vitro at fever temperatures, and we report notable fever-mediated

245 med via antigen and dendritic cells (DCs) at fever temperatures, the Th2 switch was abrogated via inc

246 via increased production of IL12 from DCs at fever temperatures.

247 t severe form, YF manifests as a hemorrhagic fever that causes severe damage to visceral organs.

248 an emerging, zoonotic, arboviral hemorrhagic fever threatening livestock and humans mainly in Africa.

249 , measles, meningitis A, rubella, and yellow fever to approximate the future deaths averted before 5

250 of therapy, with symptoms ranging from mild fever to life-threating pathology and multi-organ failur

251 ical symptoms, ranging from classical dengue fever to severe dengue hemorrhagic fever or dengue shock

252 of severity in humans from the milder dengue fever to severe disease, or dengue hemorrhagic fever (DH

253 lity associated with clinical cases of Lassa fever, together with the lack of licensed vaccines and l

254 to each other for culture-confirmed enteric fever treatment.

255 estimate the cost of illness due to enteric fever (typhoid and paratyphoid) at selected sites in Nep

256 ed with a two-day history of abdominal pain, fever up to 40 degrees C, and polyuria.

257 related to the administration of live yellow fever vaccine (YF17D-204; Stamaril).

258 Symptoms associated with yellow fever vaccine were less frequent in the TY014 group than

259 n the 1918 flu epidemic, contaminated yellow fever vaccines in World War II, and unethical human expe

260 Recent outbreaks of viral hemorrhagic fevers (VHFs), including Ebola virus disease (EVD) and L

261 ection using MSSPE arboviral or haemorrhagic fever viral panels was comparable in sensitivity to spec

262 devastating disease.IMPORTANCE African swine fever virus (ASFV) causes incurable and often lethal hem

263 African swine fever virus (ASFV) is a complex nucleocytoplasmic large

264 African swine fever virus (ASFV) is among the most complex DNA viruses

265 sothermal detection system for African Swine Fever Virus (ASFV).

266 r vaccine against Crimean-Congo haemorrhagic fever virus (CCHFV).

267 tagenomic sequencing which implicated yellow fever virus (YFV) as the etiology of this outbreak.

268 Hepatocytes are a major target of yellow fever virus (YFV) infection, and the coagulopathy in sev

269 ntibodies for dengue virus (DENV) and yellow fever virus (YFV).

270 sed large outbreaks, such as Zika and Yellow Fever Virus in Brazil.

271 he same subtype as Crimean-Congo hemorrhagic fever virus, responsible for fatal human disease.

272 lyses of mass cytometry data, we show yellow fever virus-specific cCXCR5 T cells elicited by vaccinat

273 -borne encephalitis virus, and Colorado tick fever virus.

274 iciency virus, influenza A virus, and yellow fever virus.

275 n and cell death by DENV-2, ZIKV, and yellow fever virus.

276 as dengue virus, West Nile virus, and yellow fever virus.

277 unyaviruses, La Crosse virus and Rift Valley fever virus.

278 Zika, Ebola, dengue, chikungunya and yellow fever viruses in plasma samples from infected patients.

279 Louis Encephalitis, Sindbis, and Rift Valley Fever viruses), most with substantial transmission in te

280 ses, including West Nile, dengue, and yellow fever viruses, is capable of inducing variable degrees o

281 Fever was determined to be a reliable sign of disease an

282 tory (n=32, 68%) and neurologic (n=30, 64%); fever was not commonly reported (n=9, 19%).

283 5131 cases of typhoid fever were diagnosed and 5004 Typhi isolates tested for

284 antibody responses associated with rheumatic fever were identified from 1 January 1944 to 31 July 201

285 cluding those caused by dengue, Zika, yellow fever, West Nile, and chikungunya viruses, to demonstrat

286 tions can cause life-threatening hemorrhagic fevers when they infect humans.

287 He was accompanied by fever which was persist for several days, aphthous stoma

288 nse RNA virus that causes severe hemorrhagic fever with a high fatality rate in humans in West and Ce

289 Jones criteria were used to define rheumatic fever with a maximum period of 4 weeks between disease o

290 ut, pericarditis, and familial Mediterranean fever with high antimitotic activity.

291 iation between the incidence of haemorrhagic fever with renal syndrome and the species richness of bo

292 s and incidence of rodent-borne haemorrhagic fever with renal syndrome in the human population using

293 Severe fever with thrombocytopenia syndrome (SFTS) is an emergi

294 that a nonstructural protein (NSs) of severe fever with thrombocytopenia syndrome virus (SFTSV) inter

295 the sensitivity of blood culture for enteric fever, with implications for both clinical care and surv

296 Challenged animals all developed fever within 78 hours and were treated with ciprofloxaci

297 The main clinical presentation was fever, without any specific pattern, and disseminated di

298 Yellow fever (YF) is a mosquito-transmitted viral disease that

299 Yellow Fever (YF) is an arbovirus endemic in tropical regions o

300 ted outbreaks of Chikungunya (CHIKV), Yellow fever (YFV) and Japanese encephalitis (JEV) virus in dif

301 ephalitis (JEV), West Nile (WNV), and yellow fever (YFV) viruses by intracellular cytokine staining (